Search

everythinglearnresearchcommunity

for

Search:↓

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

MC-1R is present in skin cells and may help reduce inflammation.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

Exosomal miR-222-3p reduces melanin production in rabbits by targeting the SOX10 gene.

Certain chemicals cause hair graying in black mice but not yellow mice.

Mouse melanocyte structure and function are influenced by genetics, hormones, and environmental factors.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.

A rare benign skin growth called melanocytic matricoma was identified in a 69-year-old man.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Melanocyte stem cells can become melanoma, resembling human melanoma.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

AMPK activation may reduce melanoma risk in red-haired individuals.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Melatonin affects mouse skin and may regulate skin functions.